Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer

ClinicalTrials.gov ID: NCT00609622

Public ClinicalTrials.gov record NCT00609622. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 9:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Phase 2B Study Of Sunitinib Plus Oxaliplatin, 5-Fluorouracil And Leucovorin (FOLFOX) Versus Bevacizumab Plus FOLFOX As First-Line Treatment In Patients With Metastatic Colorectal Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will compare the safety and efficacy of sunitinib in combination with FOLFOX versus bevacizumab in combination with FOLFOX for the treatment of patients with metastatic colorectal cancer who have not been treated before.

Study identification

NCT ID
NCT00609622
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
191 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2008 (Type not available)
Primary completion
Jul 2011 (Actual)
Completion
Jul 2011 (Actual)
Last update posted
Oct 11, 2012

2008 – 2011

United States locations

U.S. sites
81
U.S. states
19
U.S. cities
68
Facility City State ZIP Site status
Pfizer Investigational Site Fairhope Alabama 36532 —
Pfizer Investigational Site Mobile Alabama 36604 —
Pfizer Investigational Site Chandler Arizona 85224 —
Pfizer Investigational Site Mesa Arizona 85206 —
Pfizer Investigational Site Bentonville Arkansas 72712 —
Pfizer Investigational Site Fayetteville Arkansas 72703 —
Pfizer Investigational Site Hot Springs Arkansas 71913 —
Pfizer Investigational Site Bakersfield California 93309 —
Pfizer Investigational Site Fresno California 93720 —
Pfizer Investigational Site Fullerton California 92835 —
Pfizer Investigational Site Lancaster California 93534 —
Pfizer Investigational Site Los Angeles California 90095-1772 —
Pfizer Investigational Site Los Angeles California 90095-6984 —
Pfizer Investigational Site Los Angeles California 90095 —
Pfizer Investigational Site Mission Hills California 91345 —
Pfizer Investigational Site Northrige California 91325 —
Pfizer Investigational Site Oxnard California 93030 —
Pfizer Investigational Site Pasadena California 91105 —
Pfizer Investigational Site Redondo Beach California 90277 —
Pfizer Investigational Site Santa Barbara California 93105 —
Pfizer Investigational Site Santa Maria California 93454 —
Pfizer Investigational Site Santa Monica California 90404 —
Pfizer Investigational Site Solvang California 93436 —
Pfizer Investigational Site Valencia California 91355 —
Pfizer Investigational Site Aurora Colorado 80045 —
Pfizer Investigational Site Washington D.C. District of Columbia 20007 —
Pfizer Investigational Site Gainesville Florida 32605 —
Pfizer Investigational Site Jacksonville Florida 32204 —
Pfizer Investigational Site Jacksonville Florida 32207 —
Pfizer Investigational Site Jacksonville Florida 32258 —
Pfizer Investigational Site Jacksonville Beach Florida 32250 —
Pfizer Investigational Site Jasonville Florida 32207 —
Pfizer Investigational Site Orange Park Florida 32073 —
Pfizer Investigational Site Palatka Florida 32177 —
Pfizer Investigational Site Saint Augustine Florida 32086 —
Pfizer Investigational Site Stuart Florida 34994 —
Pfizer Investigational Site Atlanta Georgia 30341 —
Pfizer Investigational Site Decatur Georgia 30033 —
Pfizer Investigational Site Macon Georgia 31217 —
Pfizer Investigational Site Marietta Georgia 30060 —
Pfizer Investigational Site Sandy Springs Georgia 30342 —
Pfizer Investigational Site Maryville Illinois 62062 —
Pfizer Investigational Site Chanute Kansas 66720 —
Pfizer Investigational Site Dodge City Kansas 67801 —
Pfizer Investigational Site El Dorado Kansas 67042 —
Pfizer Investigational Site Independence Kansas 67301 —
Pfizer Investigational Site Kingman Kansas 67068 —
Pfizer Investigational Site Liberal Kansas 67905 —
Pfizer Investigational Site Newton Kansas 67114 —
Pfizer Investigational Site Parsons Kansas 67357 —
Pfizer Investigational Site Salina Kansas 67401 —
Pfizer Investigational Site Wellington Kansas 67152 —
Pfizer Investigational Site Wichita Kansas 67208 —
Pfizer Investigational Site Wichita Kansas 67214 —
Pfizer Investigational Site Winfield Kansas 67156 —
Pfizer Investigational Site Baltimore Maryland 21225 —
Pfizer Investigational Site Baltimore Maryland 21237 —
Pfizer Investigational Site Columbus Mississippi 39705 —
Pfizer Investigational Site Corinth Mississippi 38834 —
Pfizer Investigational Site Tupelo Mississippi 38801 —
Pfizer Investigational Site Columbia Missouri 65203 —
Pfizer Investigational Site Henderson Nevada 89052 —
Pfizer Investigational Site Las Vegas Nevada 89128 —
Pfizer Investigational Site Las Vegas Nevada 89148 —
Pfizer Investigational Site Las Vegas Nevada 89169 —
Pfizer Investigational Site Norman Oklahoma 73071 —
Pfizer Investigational Site Oklahoma City Oklahoma 73102 —
Pfizer Investigational Site Oklahoma City Oklahoma 73109 —
Pfizer Investigational Site Oklahoma City Oklahoma 73120 —
Pfizer Investigational Site Tulsa Oklahoma 74104 —
Pfizer Investigational Site Tulsa Oklahoma 74133 —
Pfizer Investigational Site Tulsa Oklahoma 74136 —
Pfizer Investigational Site Portland Oregon 97227 —
Pfizer Investigational Site Meadowbrook Pennsylvania 19046 —
Pfizer Investigational Site Philadelphia Pennsylvania 19106 —
Pfizer Investigational Site Philadelphia Pennsylvania 19107 —
Pfizer Investigational Site Radnor Pennsylvania 19087 —
Pfizer Investigational Site Willow Grove Pennsylvania 19090 —
Pfizer Investigational Site Beaumont Texas 77701 —
Pfizer Investigational Site Lubbock Texas 79415 —
Pfizer Investigational Site Wenatchee Washington 98801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00609622, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2012 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00609622 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →